agrees guidant
pharmaceutical johnson johnson medical technology guidant
guidant producer equipment combats heart implant defibrillators pacemakers aimed offsetting johnson johnson reliance slowing drug mergers drug healthcare industries fragmented pressure johnson johnson facing patent expirations battling fierce generic demand defibrillators heart electric shock irregular heartbeat rhythm detected johnson johnson guidant closing antitrust regulators overlapping stent operations stents tubes artery unblocked
